- Report
- August 2025
- 195 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- August 2025
- 189 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- August 2025
- 191 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- August 2025
- 197 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- August 2025
- 183 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- August 2025
- 185 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- August 2025
- 187 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- August 2025
- 185 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- August 2025
- 188 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- November 2025
- 279 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 181 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 279 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 166 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 382 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 274 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 278 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 369 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 274 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 375 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 390 Pages
Global
From €5220EUR$5,850USD£4,603GBP

The mRNA market within the biotechnology industry is a rapidly growing sector that focuses on the development of messenger ribonucleic acid (mRNA) technology. mRNA is a type of genetic material that is used to create proteins and is a key component of gene therapy. mRNA technology has been used to develop treatments for a variety of diseases, including cancer, heart disease, and neurological disorders. mRNA technology has also been used to develop vaccines for infectious diseases.
The mRNA market is driven by the increasing demand for mRNA-based treatments and vaccines, as well as the growing number of applications for mRNA technology. Companies in the mRNA market are focused on developing mRNA-based treatments and vaccines, as well as developing new applications for mRNA technology. Some of the major companies in the mRNA market include Moderna, BioNTech, CureVac, and Arcturus Therapeutics. Show Less Read more